Rockbridge Investment Management, Lcc Viatris Inc Transaction History

Rockbridge Investment Management, Lcc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$8.77 - $10.85 $3,911 - $4,839	-446 Reduced 66.07%	229 $2.48 Million
Q3 2022 May 28, 2024	SELL	$8.48 - $11.13 $4,248 - $5,576	-501 Closed	0 $0
Q2 2022 May 28, 2024	SELL	$9.95 - $12.27 $965 - $1,190	-97 Reduced 16.22%	501 $5,000
Q1 2022 May 28, 2024	BUY	$9.81 - $15.4 $5,866 - $9,209	598 New	598 $6,000
Q4 2021 Feb 14, 2022	SELL	$12.09 - $14.68 $48 - $58	-4 Reduced 0.59%	675 $9,000
Q3 2021 Nov 12, 2021	BUY	$13.25 - $15.13 $13 - $15	1 Added 0.15%	679 $9,000
Q2 2021 Aug 05, 2021	SELL	$12.97 - $16.15 $77 - $96	-6 Reduced 0.88%	678 $10,000
Q1 2021 May 20, 2021	SELL	$13.59 - $18.54 $6,591 - $8,991	-485 Reduced 41.49%	684 $10,000
Q4 2020 Mar 04, 2021	BUY	$14.3 - $18.74 $16,716 - $21,907	1,169 New	1,169 $22,000

1,141

988M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.1B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.